What Researchers Did
Researchers conducted a nationwide population-based registry study in Denmark to investigate the association between hyperbaric oxygen treatment and 30-day mortality in patients with necrotising soft-tissue infection.
What They Found
A total of 671 NSTI patients were included, with an overall 30-day mortality of 19% (95% CI 17% to 23%). Patients receiving HBO2 treatment (n=266) were younger and had lower SAPS II scores, but a larger fraction had septic shock compared to those not receiving HBO2.
What This Means for Canadian Patients
While the specific impact of hyperbaric oxygen treatment on mortality was not fully detailed in the provided abstract, managing necrotising soft-tissue infections remains a critical challenge for Canadian healthcare providers. Multidisciplinary approaches, including potential adjunctive therapies like HBO2, require careful consideration based on patient severity and available resources.
Canadian Relevance
This study was conducted in Denmark and does not have a direct Canadian connection.
Study Limitations
As a registry study, it may be subject to limitations such as data completeness or unmeasured confounding variables.